These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11884941)

  • 1. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells.
    Boulday G; Hamann J; Soulillou JP; Charreau B
    Transplantation; 2002 Feb; 73(3):429-36. PubMed ID: 11884941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
    Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
    J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenogeneic serum promotes leukocyte-endothelium interaction under flow through two temporally distinct pathways: role of complement and nuclear factor-kappaB.
    Morigi M; Zoja C; Colleoni S; Angioletti S; Imberti B; Donadelli R; Remuzzi A; Remuzzi G
    J Am Soc Nephrol; 1999 Oct; 10(10):2197-207. PubMed ID: 10505697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
    Hamann J; Vogel B; van Schijndel GM; van Lier RA
    J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.
    Charreau B; Ménoret S; Tesson L; Azimzadeh A; Audet M; Wolf P; Marquet R; Verbakel C; Ijzermans J; Cowan P; Pearse M; d'Apice A; Soulillou JP; Anegon I
    Mol Med; 1999 Sep; 5(9):617-30. PubMed ID: 10551903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions.
    Gallego MJ; Zoja C; Morigi M; Micheletti G; Imberti B; Foppolo M; Remuzzi A; Remuzzi G
    Am J Kidney Dis; 1996 Jul; 28(1):23-31. PubMed ID: 8712218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
    Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
    Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors.
    Lorenzon P; Vecile E; Nardon E; Ferrero E; Harlan JM; Tedesco F; Dobrina A
    J Cell Biol; 1998 Sep; 142(5):1381-91. PubMed ID: 9732297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
    Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
    Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
    Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
    J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.